CoChat

Diagnostic yield of targeted massively parallel sequencing in children with epileptic encephalopathy

Open access
Kothur, Kavitha, Holman, Katherine, Farnsworth, Elizabeth, Ho, Gladys, Lorentzos, Michelle, Troedson, Christopher, Gupta, Sachin, Webster, Richard, Procopis, Peter G., Menezes, Manoj P., Antony, Jayne, Ardern-Holmes, Simone, Dale, Russell C., Christodoulou, John, Gill, Deepak, Bennetts, Bruce · 2018 · Seizure
Cited by 77

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

PURPOSE To report our institutional experience of targeted massively parallel sequencing (MPS) testing in children with epilepsy. METHOD We retrospectively analysed the yield of targeted epileptic encephalopathy (EE) panel of 71 known EE genes in patients with epilepsy of unknown cause, who underwent clinical triage by a group of neurologists prior to the testing. We compared cost of the EE panel approach compared to traditional evaluation in patients with identified pathogenic variants. RESULTS The yield of pathogenic variants was 28.5% (n = 30/105), highest in early onset EE <3 months including Ohtahara syndrome (52%, n = 10/19) and lowest in generalized epilepsy (0/17). Patients identified with pathogenic variants had earlier onset of seizures (median 3.6 m vs 1.1y, p < 0.001, OR 0.6/year, P < 0.02) compared to those without pathogenic variants. Pathogenic/likely pathogenic variants were found in ALDH7A1 (2), CACNA1A (1), CDKL5 (3), FOXG1 (2), GABRB3 (1), GRIN2A (1), KCNQ2 (4), KCNQ3 (1), PRRT2 (1), SCN1A (6), SCN2A (2), SCN8A (2), SYNGAP1 (1), UBE3A (2) and WWOX (1) genes. This study expands the inheritance pattern caused by KCNQ3 mutations to include an autosomal recessive severe phenotype with neonatal seizures and severe developmental delay. The average cost of etiological evaluation was less with early use of EE panel compared to the traditional investigation approach ($5990 Australian dollars (AUD) vs $13069 AUD ; p = 0.02) among the patients with identified pathogenic variants. CONCLUSION Targeted MPS testing is a comprehensive and economical investigation that enables early genetic diagnosis in children with EE. Careful clinical triage and selection of patients with young onset EE may maximize the yield of EE panel testing.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.seizure.2018.05.005

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 77

Metadata

Authors
Kothur, K., Holman, K., Farnsworth, E., Ho, G., Lorentzos, M., Troedson, C., Gupta, S., Webster, R., Procopis, P. G., Menezes, M. P., Antony, J., Ardern-Holmes, S., Dale, R. C., Christodoulou, J., Gill, D., & Bennetts, B.
Venue
Seizure
Publisher
Elsevier BV
Published
2018-07
Volume
59
Pages
132-140
ISSN
1059-1311 (ISSN-L)
OpenAlex
W2799744427
Cited by
77
References
6
FWCI
7.11
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Diagnostic yield of targeted massively parallel sequencing in children with epileptic encephalopathy. https://app.cochat.ai/papers/10.1016/j.seizure.2018.05.005
The paper
Kothur, K., Holman, K., Farnsworth, E., Ho, G., Lorentzos, M., Troedson, C., Gupta, S., Webster, R., Procopis, P. G., Menezes, M. P., Antony, J., Ardern-Holmes, S., Dale, R. C., Christodoulou, J., Gill, D., & Bennetts, B. (2018). Diagnostic yield of targeted massively parallel sequencing in children with epileptic encephalopathy. Seizure. https://doi.org/10.1016/j.seizure.2018.05.005

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.